Dear Readers: Thank you for your steadfast connection to your professional Medical Affairs community through reading, supporting, and contributing to The MSL Journal.  Your investment in learning, growing, and developing, as well as giving back to others through sharing your articles, makes this publication so valuable in an era where showing value is vital now more than … [Read more...]

Within the pharmaceutical industry, the Medical Affairs department serves a critical strategic function as a link between internal scientific innovation and external clinical engagement. Some of these critical functions include data dissemination, evidence generation, KOL relationship management, and insight analysis. The department has been crucial in translating science into … [Read more...]

An Interview with Dr. Richard Ingebretsen, Program Director, University of Utah School of Medicine Each summer, an exceptional program is conducted by the University of Utah School of Medicine in Chamonix, in the heart of the French Alps, an intensive two-week Wilderness Medicine and Rescue course that combines classroom instruction with field-based medical training. … [Read more...]

Introduction and objectives The Medical Science Liaison (MSL) role is increasingly recognized as a cornerstone of the pharmaceutical industry, offering professionals a dynamic opportunity to contribute to scientific development while fostering strong collaborations with healthcare practitioners. As the demand for MSLs continues to grow, understanding the pathways that lead … [Read more...]

Aspiring Medical Science Liaisons (MSLs) and MSLs in career transition often face the challenge of staying competitive without access to proprietary tools or institutional resources. Yet, they must demonstrate strategic thinking, scientific fluency, and familiarity with the research landscape to break into or return to the pharmaceutical industry. In this context, publicly … [Read more...]

Advancing medical strategy through scientific engagement and knowledge generation remains fundamental for the Medical Affairs department in pharmaceutical companies. Demonstrating the value they bring to healthcare and access systems by improving patients' lives with innovative products is now indispensable. Impact measurement is key to understanding the real value of … [Read more...]

I. Overview and Purpose While the roles, responsibilities, and titles of Field Based Medical (FBM) personnel vary in each organization, they are universally viewed as the scientific experts of the pharmaceutical/biopharmaceutical company and engage in unbiased scientific discussions. Their role encompasses the lifecycle of a product, including pre-approval pipeline assets … [Read more...]

African healthcare lags behind major healthcare systems generally due to its inadequate infrastructure, limited disease prevention strategies, and shortage of healthcare providers to serve a growing population. Over the last decade, several African countries have made strategic investments in their medical facilities, making significant strides in improving healthcare … [Read more...]

Research Science Liaisons – We're like MSLs, Only the Opposite When we first meet with Medical Science Liaisons (MSLs), they are often confused about our role. We can’t blame them – our position is unique and very few cancer centers have a role like ours. Our 30-second “pitch” to MSLs is always “We are like you, only the opposite”. Lineberger Comprehensive Cancer Center … [Read more...]

Medical Science Liaisons typically operate at the intersection of deep scientific knowledge, high-stakes communication, and strategic business alignment. It’s a rewarding role—but for many, there’s an unexpected emotional hurdle that goes unspoken: Imposter Syndrome. Despite our advanced degrees, scientific expertise, and years of extensive training, many of us quietly carry … [Read more...]

The implementation of effective communication strategies in the medical-scientific and pharmaceutical business context is essential to ensure accurate dissemination of information, promote collaboration among stakeholders, and support regulatory and marketing objectives. In an industry where credibility, clarity, and compliance are crucial, strategic communication serves as a … [Read more...]

For years, the MSL role has been described as a bridge between clinical data and real-world practice, between biopharma and physicians, between innovation and patient care. But what if the real opportunity isn’t being the bridge — it’s becoming the architect? The most successful interactions in the field rarely start with a presentation. They start with curiosity, … [Read more...]

“Leaders don’t look backwards to condemn what has already been done; they look forward to create a better future” – Mark Cuban As MSLs, we navigate a fine balance between adhering to proven, long-standing processes and innovating to keep pace with today's evolving technological and healthcare landscape. In this article, I aim to help you understand how being a disruptive … [Read more...]

1. Introduction: From the Margins to the Core of Strategy It was 1967 when Upjohn Pharmaceuticals introduced a novel role designed to bridge the widening gap between clinical science and medical practice: the Medical Science Liaison (MSL). Initially envisioned as a non-promotional channel for scientific exchange, the MSL emerged in response to growing demands for … [Read more...]

One of the most common phrases I heard from my professors at medical school at the Universidad de Caldas, in Manizales, Colombia, was “He who only knows about medicine, knows nothing.” This was a widespread sentiment among my mentors, teachers, and colleagues, promoting splitting our studies with learning about other areas that enrich our culture, stimulate our brains in a … [Read more...]

Why the need to supercharge? Because traditional clinical trial recruitment strategies may not be enough in 2025. The challenges of clinical trial recruitment have long been a pain point in the pharmaceutical and biotechnology industries. With increasing complexity in trial designs and heightened competition for trial participants, Medical Affairs Organizations and … [Read more...]

The strategic value MSLs offer to therapeutic areas is without question. Yet, tapping that value is dependent on how effective MSLs are in reaching, educating, and satisfying their physician targets. These efforts can offer a significant challenge considering the time constraints on today’s HCPs/KOLs. It is, therefore, not surprising that a recent global survey by First Word … [Read more...]

As a Medical Science Liaison (MSL), identifying relevant Key Opinion Leaders (KOLs) in a sea of credentials, publications, and affiliations is a nuanced challenge  In a role where scientific engagement drives strategic success, finding and connecting with the right key opinion leaders isn't just a core responsibility; it's central to meeting the set objectives. But relying … [Read more...]